Scott Dessain

Scott Dessain, MD, PhD, is the Chair of the Scientific Advisory Board and co-founder of Immunome. He is the Joseph and Ray Gordon Chair of Clinical Oncology and Research at Lankenau Institute for Medical Research (LIMR) and serves as the Director, Center for Human Antibody Technology (CHAT) at LIMR. He received MD and PhD degrees from Yale University in 1994. He pursued post-graduate medical training in Internal Medicine at Brigham and Women’s Hospital, followed by a fellowship in Medical Oncology at Dana Farber/Partners Cancer Care in Boston, MA. He studied with Dr. Robert Weinberg at the Whitehead Institute in Cambridge, MA, at which time he devised novel techniques to efficiently clone native human antibodies. Following his fellowship, Scott practiced at the Massachusetts General Hospital in Boston, specializing in bone marrow transplantation and then joined the Cardeza Foundation for Hematologic Research at the Thomas Jefferson University in Philadelphia. He has contributed to dozens of published scientific articles and multiple patents and is co-author (with Scott Fishman) of the book: Preserving the Promise: Improving the Culture of Biotech Investment (2016; Academic Press, Cambridge, MA). He is Board-Certified in Medical Oncology and attends at the Lankenau Hospital.